September 22, 2020

COVID-19 Updates: What it Means For You

In May the NPF formed the NPF COVID-19 Task Force to help serve the psoriatic disease community by closely monitoring evolving data and advances. This Task Force is led by Co-Chairs, dermatologist Dr. Joel Gelfand (Director, Psoriasis and Phototherapy Treatment Center at Penn) and rheumatologist Dr. Christopher Ritchlin (Co-Director, Psoriasis Center and Director of the Clinical Immunology Research Unit, University of Rochester Medical Center) and includes experts from both the NPF Medical Board and Scientific Advisory Committee, as well as experts in dermatology, rheumatology, infectious disease and critical care.

Watch this webinar to hear Dr. Gelfand and Dr. Ritchlin explain the 22 guidance statements for psoriatic disease, what they mean for your psoriatic disease management during this pandemic, and the work of the Task Force. Discussion includes many of the questions you have about the use of biologics during the COVID-19 pandemic. You don’t want to miss this webinar!


Contact Bev Bromfield, Outreach Manager, at or 800-723-9166, ext. 362.

The views and opinions expressed in the webinars are those of the speakers. The speakers' views and opinions are not endorsed by the National Psoriasis Foundation or its sponsors.

Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.